PH30109A - Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same - Google Patents

Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same

Info

Publication number
PH30109A
PH30109A PH46601A PH46601A PH30109A PH 30109 A PH30109 A PH 30109A PH 46601 A PH46601 A PH 46601A PH 46601 A PH46601 A PH 46601A PH 30109 A PH30109 A PH 30109A
Authority
PH
Philippines
Prior art keywords
production
crystalline hydrate
triazolylthiomethylthio
hydroclhloride
cephalosporin
Prior art date
Application number
PH46601A
Other languages
English (en)
Inventor
Hisanori Takahashi
Yutaka Ide
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of PH30109A publication Critical patent/PH30109A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH46601A 1992-07-31 1993-07-29 Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same PH30109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20496592 1992-07-31

Publications (1)

Publication Number Publication Date
PH30109A true PH30109A (en) 1996-12-27

Family

ID=16499234

Family Applications (1)

Application Number Title Priority Date Filing Date
PH46601A PH30109A (en) 1992-07-31 1993-07-29 Triazolylthiomethylthio cephalosporin hydroclhloride its crystalline hydrate and the production of the same

Country Status (23)

Country Link
US (1) US5407929A (de)
EP (1) EP0581552B1 (de)
KR (1) KR100245938B1 (de)
CN (1) CN1037683C (de)
AT (1) ATE165360T1 (de)
AU (1) AU657866B2 (de)
BR (1) BR9303235A (de)
CA (1) CA2101502A1 (de)
DE (1) DE69318077T2 (de)
ES (1) ES2115725T3 (de)
FI (1) FI933391A7 (de)
GR (1) GR3026699T3 (de)
HU (1) HU219637B (de)
IL (1) IL106516A (de)
MX (1) MX9304611A (de)
NO (1) NO303734B1 (de)
NZ (1) NZ248285A (de)
PH (1) PH30109A (de)
PL (2) PL172835B1 (de)
RU (1) RU2118959C1 (de)
TW (1) TW307769B (de)
UA (1) UA37181C2 (de)
ZA (1) ZA935529B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1368349B1 (de) * 2001-02-24 2007-02-14 Boehringer Ingelheim Pharma GmbH & Co.KG Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) * 2002-03-21 2003-09-29 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en) 2002-11-12 2004-04-27 Kansas State University Research Foundation Compounds affecting cholesterol absorption
CN101219992B (zh) 2003-02-12 2011-08-31 日产化学工业株式会社 匹伐他汀钙的晶形
ES2329244T3 (es) 2003-03-27 2009-11-24 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2540725A1 (de) 2006-05-04 2013-01-02 Boehringer Ingelheim International GmbH Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
WO2009024542A2 (en) * 2007-08-17 2009-02-26 Boehringer Ingelheim International Gmbh Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
NZ604091A (en) * 2008-08-15 2014-08-29 Boehringer Ingelheim Int Purin derivatives for use in the treatment of fab-related diseases
CN102149407A (zh) 2008-09-10 2011-08-10 贝林格尔.英格海姆国际有限公司 治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh) 2008-12-23 2011-11-23 贝林格尔.英格海姆国际有限公司 有机化合物的盐形式
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20240090632A (ko) 2009-11-27 2024-06-21 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CN102946875A (zh) 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
WO2011161161A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en) 2011-07-15 2014-11-11 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
JP6224084B2 (ja) 2012-05-14 2017-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (de) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medizinische verwendung eines dpp-4-inhibitors
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES475573A1 (es) * 1977-07-12 1980-01-16 Fujisawa Pharmaceutical Co Un procedimiento para preparar nuevos compuestos de cefem
IE65926B1 (en) * 1990-07-19 1995-11-29 Shionogi & Co Thioalkylthio cephalosporin derivatives

Also Published As

Publication number Publication date
NO932745L (no) 1994-02-01
CN1089948A (zh) 1994-07-27
ZA935529B (en) 1994-02-24
NO303734B1 (no) 1998-08-24
BR9303235A (pt) 1994-03-01
KR940005636A (ko) 1994-03-22
RU2118959C1 (ru) 1998-09-20
EP0581552A3 (en) 1994-06-01
FI933391L (fi) 1994-02-01
FI933391A7 (fi) 1994-02-01
FI933391A0 (fi) 1993-07-29
PL299870A1 (en) 1994-02-07
DE69318077D1 (de) 1998-05-28
PL172835B1 (pl) 1997-12-31
AU4422793A (en) 1994-02-03
CA2101502A1 (en) 1994-02-01
EP0581552B1 (de) 1998-04-22
TW307769B (de) 1997-06-11
HU219637B (hu) 2001-06-28
HUT68602A (en) 1995-06-28
CN1037683C (zh) 1998-03-11
MX9304611A (es) 1994-02-28
GR3026699T3 (en) 1998-07-31
ES2115725T3 (es) 1998-07-01
EP0581552A2 (de) 1994-02-02
US5407929A (en) 1995-04-18
IL106516A (en) 1998-06-15
IL106516A0 (en) 1993-11-15
ATE165360T1 (de) 1998-05-15
AU657866B2 (en) 1995-03-23
DE69318077T2 (de) 1998-10-29
PL172830B1 (pl) 1997-12-31
KR100245938B1 (ko) 2000-04-01
NO932745D0 (no) 1993-07-30
HU9302194D0 (en) 1993-10-28
UA37181C2 (uk) 2001-05-15
NZ248285A (en) 1994-07-26

Similar Documents

Publication Publication Date Title
AU657866B2 (en) Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same
AU616838B2 (en) N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives
AU6787690A (en) Amino acid derivatives
AU4236889A (en) Imidazoline derivative and preparation thereof
MY104937A (en) Cephalosporin derivatives and processes for their preparation
IL91001A0 (en) N-alkyl derivatives of antibiotic bu-3608 complex and pharmaceutical compositions containing them
EP0416810A3 (en) Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
EP0416814A3 (en) Cephalosporin compounds, process for their preparation, pharmaceutical compositions and intermediates
NZ218227A (en) Cephalosporin derivatives and pharmaceutical compositions
HUT53654A (en) Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds